Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment
Suzanne Nielsen, Natasa Gisev, Raimondo Bruno, Wayne Hall, Milton Cohen, Briony Larance, Gabrielle Campbell, Marian Shanahan, Fiona Blyth, Nicholas Lintzeris, Sallie Pearson, Richard Mattick, Louisa Degenhardt
Pharmacoepidemiology and Drug Safety | WILEY | Published : 2017
Awarded by Australian National Health and Medical Research Council (NHMRC)
Awarded by NHMRC
Thanks to Jessica Belcher, Sarah Freckleton, Bianca Hoban, Anika Martin, Ranira Moodley and Kimberly Smith NDARC, for their contribution to data collection, project investigators Michael Farrell, Tim Dobbins and the POINT advisory committee for their advice on the design and conduct of the larger study. This study received funding from the Australian National Health and Medical Research Council (NHMRC, #1022522). SN, NG, BL and LD are supported by NHMRC research fellowships (#1013803, #1091878, #1073858 and #1041472). The National Drug and Alcohol Research Centre at the University of NSW is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund.